Brief: Two Pure Biologics Projects Are Recommended For Poland's Medical Research Agency Subsidy

Multiqure SA

22/11/2022 08:25

Nov 22 (Reuters) - Pure Biologics SA  PUR1.WA :
    * TWO PROJECTS ARE RECOMMENDED TO RECEIVE POLAND'S MEDICAL
RESEARCH AGENCY SUBSIDY
    * FIRST PROJECT IS TITLED 'PHASE 1 STUDY OF FIRST-IN-CLASS
BISPECIFIC ROR1XCD16 MOLECULE IN PATIENTS WITH B CELL LYMPHOID
MALIGNANCIES'
    * TOTAL WORTH OF FIRST PROJECT IS 50.0 MILLION ZLOTYS AND
POLAND'S
MEDICAL RESEARCH AGENCY RECOMMENDED SUBSIDY OF 32.4 MILLION
ZLOTYS
    * TOTAL WORTH OF SECOND PROJECT IS 50.0 MILLION ZLOTYS AND
POLAND'S MEDICAL RESEARCH AGENCY RECOMMENDED SUBSIDY OF 30.1
MILLION ZLOTYS
    * TITLE OF SECOND PROJECT IS 'PHASE 1 STUDY OF
MULTIFUNCTIONAL
QUAD-DM1 IN GLIOBLASTOMA PATIENTS'

Source text for Eikon:  ID:nEM301nhda 
Further company coverage:  PUR1.WA 
 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))